Connecticut Attorney General William Tong announced four separate settlements with hearing aid companies: Lively Hearing Corporation, Widex USA, Inc., Hark Wellness, Inc., and Wonder Ear, Inc., who marketed their products as “FDA-approved” despite no such approval.
Hearing aids currently do not receive approval from the United States Food and Drug Administration (FDA) in the same manner as new drugs and some medical devices; however, hearing aid manufacturers register their products with the FDA.
Although Congress enacted legislation in 2017 permitting the FDA to create a category of over-the-counter (OTC) hearing aids, the FDA has not yet issued a final rule and no hearing aid suppliers should be marketing their products as OTC or “FDA-approved.”
Related Posts
Academy Pushes for Expanded Medicare Beneficiary Access
The Academy teamed up with the Academy of Doctors of Audiology (ADA) and the American Speech-Language-Hearing Association (ASHA) to push for expanded Medicare beneficiary access…
Medicare Resources for Providers and Suppliers in FEMA-Designated Disaster Zones
The Centers for Medicare and Medicaid Services (CMS) has announced the availability of accelerated and advanced Medicare payments for eligible providers and suppliers who are…
NCSB Annual Conference and ASLP-IC Progresses
This past weekend, the National Council of State Boards (NCSB), which represents audiology licensure boards, held its annual conference in San Antonio, Texas. In this…